For the trading desk
Markets, order characteristics and the proposed execution arrangement.
Market coverageWhy Drovix / evaluation brief
Liquidity with its own market-making and bridge technology.
Evaluate the counterparty and the technology together. Drovix’s proposition connects institutional liquidity with the engineering behind pricing and broker connectivity.
Discuss your requirementsWhat to evaluate.
An outline for your review. The applicable capabilities and terms are confirmed during the counterparty discussion.
| Area | Drovix’s contribution | Questions for your review |
|---|---|---|
| Liquidity counterparty | Drovix acts as principal in a bilateral OTC relationship with an approved institution. | Permitted instruments, pricing arrangements, terms of dealing and counterparty eligibility. |
| Own market-making technology | Pricing and risk are part of Drovix’s in-house technology work, alongside its role as a liquidity provider. | The proposed pricing profile, exposure boundaries and the conditions relevant to your order flow. |
| Own bridge technology | Connectivity links the broker platform and institutional execution environment. | Platform interfaces, symbol mapping, order states, failure handling and reconciliation. |
A practical fit discussion
Bring the architecture you already operate.
The starting point can be a broker platform, an OMS or a systematic execution workflow. Describe the constraints before settling the integration.
For engineering
Interfaces, message handling and the boundary between your systems and Drovix.
Technology overviewFor risk
Approved scope, exposure, limits and the conditions that would change them.
Risk and controlsFor operations
Documentation, reconciliation and the handling of operational exceptions.
Operational referenceCounterparty terms
The agreement defines the service.
Commercial terms, instrument access and risk arrangements are set for the approved relationship. A website overview is the beginning of the evaluation; the executed agreement and schedules govern the activity.
Leveraged OTC products, including Forex and CFDs, carry a high level of risk and a counterparty may lose more than its initial margin. The Drovix offering is directed exclusively at Eligible Counterparties and Professional Clients; Drovix does not provide services to retail clients.